Member Info for K3VMC

No proposed dates as yet.

Tarouca tungsten and tin exploration licence is a former scheelite mine covering 5.7km�. In 2015, trench sampling at the Tarouca project showed high-grade tungsten results with 15 out of 126 samples exceeding 0.5% WO3, including 0.8 m at 11.4% WO3 (TTR063). Together with the 15 holes drilled in 2014, this confirms an outstanding exploration target in the north eastern area of the licence. So, not only is it tungsten and tin, with very high grades in places, it is only 20km from Regua. It also has copper. WHo knows what else it has there? Maybe it has some stuff that no-one thought to look for, when the mine was operational. As for Sao Martinho, we already have a JORC for 100koz Au. In July, we may be told that we have 500koz Au, or maybe even a lot more than that. What does it matter that we drill a few extra holes? If they get another four samples, 53m deep with visible gold, The market will most definitely sit up and take notice. Yes, definitely concentrate on getting the LP cash fountain gushing in 2019. My view is that we will see a lot closer to $40m ebitda, than $20m ebitda, but there has to be a long term strategy, and that has to be based on exploration results. He can drill, produce, pay down BR and STILL have enough free cash flow for a 0.1p dividend. All IMHO.

Agreed. Very confident and very relaxed. I liked the reference to 500koz Au, obviously (as a starting point with more to come), but the best part was the �new assets that can bring significant rewards for shareholders for very minimal outlay, because we have a great technical team�, or however it was he put it. Especially now the EU is providing funding for drilling.

One of these is top of my list. https://hartley-botanic.co.uk/product/the-victorian-grand-manor-glasshouse/

Head Herring speaks. https://twitter.com/thestocktube/status/1004649164947550208?s=21

Egg, it was all just a matter of time and timing. I couldn�t do anything about time and I got my timing wrong for most of that time, but I just buy in as I get funds. I stand by all the times I posted that I will not care about the tenths of pennies I �overpaid� when the sp is 5p plus.

Noplus, why do you give a hoot? Oh, ok. Just another FUD. Rock on!

Define �now�. In due course, Lupuzor goes to market. You do not throw away a treatment for up to three million sufferers. More effective than Benlysta. Safer than Benlysta. They will get that through to the FDA.

You have no honour.

Ask Barclays for a letter of representation. That lets you vote at the agm, but you can still attend. Last year, we had to go find some more seats. The room is very small though. We may have to stand!!

Never had so much as an egg sandwich, but we can make up for it when we get to Merida. Chilli tripe, pigs cheek, pata negra, manchego, Rioja...... Bring a larger pair of trousers.

Leas, you see the difference between you and a troll, writ large? Contrary views are great, especially when they contrast so effectively with bombastic egoists or the super-snide residents of this board. Very poor manners, imho.

Leas I am not a Troll which seems to be a term used for someone with a contrary view but these are the facts. Lupuzor does work for many Lupus sufferers but the placebo and after care also benefited some patients. I have no problem with contrary views and i agree that placebo and special care benefitted some patients.

Yes, there is a typo in the last sentence. I apologise. It should read: They have failed in that they have not succeeded. If they succeed NOW, they have not failed ultimately, which is what I am interested in. Can you at least understand the sense now? I would never expect you to agree with it, of course.

You have no need to reveal who you are. Every post you make confirms it.

Safetyman, no ticket required! If you want to vote, bring your share certs or ask your broker for a letter of representation. Green Park is the nearest tube station. Probably Mr Garvie and Mr Scott will attend, so worth the trip just for that.

Excellent!! Now, if you can use that to get to a train station, then you can get to Kings Cross station in London? I can meet you there and act as a local guide, negotiating safe passage with the natives to take you to the great Wres meeting place.

So, you did not say that I posted anything incorrect. Good. What you did post was: Is this a bot or are there brains behind these repeated mechanical posts ? Not a bot and brains of sorts. If you really want to make money with this share you cannot hope of fooling anybody with repeating that a subgroup was positive and that the market for that subgroup alone is huge. Yes, I want to make money. No, I am not trying to fool anybody. The sub-group represents a massive three million sufferers in the real world and, therefor, the market IS huge. You are only fooling yourself if you keep doing that. I am not fooling myself. I post these facts to counter the vested interests of trolls. The message should be: the ph3 was not a ph3, it failed big time due to a flawed design and screaming underpowering. I would have preferred that the p3 only had antibody positive patients. I do not know why that did not happen and I am not prepared to speculate why that did not happen. If there were only antibody positive patients, and if there had been a larger sample of same, I expect that the P3 trial would have been a resounding success, since 71% of patients benefitted from Puluzor. The company is run by the same duo since day 1, for 13 years. You have to realise that it is literally a 2 men (DD + RZ) company, with an IR on steroids (TM). Point taken. The lack of breadth of the organisation is a reason alone for pharma not to engage in serious discussions. Disagree. A potential blockbuster will attract suitors. And if they do, based on the merits of Lupuzor, they will literally blackmail the company, applying a planet sized discount to RZ�s planet sized valuation of the asset. The reason they will do that is that they know that IMM has hit a roadblock, in terms of credibility and in terms of capacity to finance a new trial. That is what competition is for. They have failed consistently. They have to find another home for Lupuzor or other hands to take over the development. They have to go. If they don�t get it, the share price has to remind them of this inescapable reality. They have failed in that they have not succeeded. If they succeed not, they have not failed ultimately, which is what I am interested in

Safetyman, do you live anywhere near a bus stop?

Pardon me? Of course it is Stephen Beetham. Not that that means anything special, in terms of being right or wrong about PANR. It is all about value. You either think something is worth buying / selling at a particular price, or you do not. The sleazy part of bulletin boards is where you talk your own book, to get to your buy / sell price. Cheap and shoddy behaviour.